BioPharma Credit (LSE:BPCR) Total Noninterest Expense : $1.9 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Total Noninterest Expense?

BioPharma Credit's Total Noninterest Expense for the six months ended in Dec. 2022 was $1.0 Mil. BioPharma Credit's Total Noninterest Expense for the trailing twelve months (TTM) ended in Dec. 2022 was $1.9 Mil.

BioPharma Credit Total Noninterest Expense Historical Data

The historical data trend for BioPharma Credit's Total Noninterest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Total Noninterest Expense Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Noninterest Expense

Get a 7-Day Free Trial

1.79

2.22

3.01

1.93

2.04

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
Total Noninterest Expense	Get a 7-Day Free Trial							1.69	1.32	0.89	1.05	-

BioPharma Credit Total Noninterest Expense Calculation

Total Noninterest Expense is any expenses incurred that not related to interest. It includes:
Selling, General, & Admin. Expense
Occupancy
Equipment
Professional fees
Amortization of intangibles
Any other special income/charges (too numerous to list)
Some banks can do choose to report each of these items separately. Yet, there are a variety of noninterest expense which are simply too numerous to list.

Total Noninterest Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.9 Mil.

BioPharma Credit Total Noninterest Expense Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Total Noninterest Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Total Noninterest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines